Expression Analysis expressionanalysis.com


Public list: Digital Health (6206) Genomics (575) Pharma Startups (4740)

Expression Analysis is a provider of genomics testing and analysis to biopharma, academic, government and non-profit customers. EA provides whole genome to focused-set gene expression and genotyping assays, along with next-generation sequencing services, sequence enrichment technologies and bioinformatics support. It offers a broad range of services across multiple platforms. Its quality system follows CLSI guidelines and its CLIA-registered laboratory supports GLP compliance. In August 2012,...Show all

Expression Analysis is a provider of genomics testing and analysis to biopharma, academic, government and non-profit customers. EA provides whole genome to focused-set gene expression and genotyping assays, along with next-generation sequencing servi...Show all

Company (Acquired)

Phone:

Fax:

4324 South Alston Avenue
Durham, 27713
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Expression Analysis $0M Aug 14, 2012
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Expression Analysis Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Transgenomic

Omaha, Nebraska, United States
Alive / ActiveTransgenomic (NASDAQ:TBIO) is a global biotechnology company that advances personalized medicine in oncology and inherited diseases via its products and services for automated high-sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery, and laboratory testing services to the academic and medical research, clinical laboratory, and biopharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Their flagship product is ICE ...Show allLogin to see details

HTG Molecular Diagnostics

Tucson, Arizona, United States
IPO / Went publicHTG Molecular Diagnostics provides simple, cost effective solutions for accurate RNA testing. In 2013 the company commercialized its Edge instrument platform and a portfolio of mRNA assays that leverage HTG's proprietary nuclease protection chemistry. The capability of the Edge System has been expanded to fully automate sample and targeted library preparation for next-generation sequencing.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)